相关实验视频

Updated: Jun 30, 2025

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

在糖尿病足中VEGF刺激的效果:一个系统的审查

Frederik S Bang¹, Veronica Leeberg², Ming Ding³

¹Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society

|March 18, 2024

概括

血管内皮生长因子 (VEGF) 在加速糖尿病足愈合方面表现有前途. 在大多数研究中,局部VEGF治疗表明伤口的关闭速度更快,这表明其潜在的治疗益处.

科学领域:

再生医学是一种再生医学.
伤口治愈研究研究伤口治愈研究
糖尿病并发症糖尿病并发症

背景情况:

糖尿病足 (DFU) 是一种严重的糖尿病并发症,通常导致截肢.
在DFU中血管不足会损害自然愈合过程.
血管内皮生长因子 (VEGF) 促进血管新生,并被探索为DFU治疗.

研究的目的:

在过去的16年里,系统地审查关于VEGF刺激对DFU治疗的体外研究.
评估VEGF在促进DFU中伤口愈合方面的疗效和安全性.
确定DFU中VEGF治疗的未来研究方向.

主要方法:

对DFU的VEGF进行的体外研究进行系统审查.
在数据库中进行文献搜索,确定了961篇文章.
包括四项符合特定分析标准的研究.

主要成果:

在四项研究中,有三项报告说VEGF治疗的DFU在统计上愈合得更快.
一项研究显示,使用VEGF.加速愈合的积极趋势.
所有包括的研究都支持VEGF的使用,并指出其在人类局部应用中的安全性.

结论:

VEGF在加速DFU愈合方面表现出积极的趋势,并且在局部上看起来是安全的.
需要进一步的研究来优化VEGF剂量,释放率和DFU的机制.
标准化研究设计对于可比性和临床可转化结果至关重要.

关键词:

血管新生是因为血管新生.糖尿病人的足部.电话电信 (Telbermin) 是一个电信系统.血管内皮生长因子血管内皮生长因子伤口愈合伤口愈合

更多相关视频

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits

Published on: June 2, 2019

A Simplified Technique for Producing an Ischemic Wound Model

A Simplified Technique for Producing an Ischemic Wound Model

Published on: May 2, 2012

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...